{"product_id":"rheumnow-live-2024","title":"RheumNow Live 2024","description":"\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\r\n\u003ch1 class=\"product_title entry-title\"\u003eRheumNow Live 2024\u003c\/h1\u003e\r\n\u003cstrong\u003e+ Include: 42 videos, size: 35.05 GB\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Target Audience: rheumatologists and clinical immunologists\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Information:\u003c\/strong\u003e\r\n\u003ch2 data-path-to-node=\"0\"\u003e1. Overview\u003c\/h2\u003e\r\n\u003cp data-path-to-node=\"1\"\u003eThe RheumNow Live 2024 course provides a comprehensive clinical update on the diagnosis and management of complex rheumatic and autoimmune diseases. The program features expert-led sessions on the latest therapeutic advancements, clinical guidelines, and emerging biomarkers across core rheumatology domains, including SLE, rheumatoid arthritis, psoriatic disease, and spondyloarthritis.\u003c\/p\u003e\r\n\u003cp data-path-to-node=\"1\"\u003e\u003cb data-path-to-node=\"1\" data-index-in-node=\"388\"\u003eCourse Date:\u003c\/b\u003e 2024\u003c\/p\u003e\r\n\r\n\u003ch2 data-path-to-node=\"2\"\u003e2. Learning Objectives\u003c\/h2\u003e\r\n\u003cul data-path-to-node=\"3\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,0,0\"\u003eEvaluate the biology of lupus flares and implement emerging biomarkers for the accurate diagnosis and treatment of SLE.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,1,0\"\u003eApply updated ACR, EULAR, and GRAPPA guidelines for the selection of systemic therapies in psoriatic disease and spondyloarthritis.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,2,0\"\u003eAssess the clinical efficacy, safety concerns, and expanding applications of JAK inhibitors within the rheumatology treatment paradigm.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,3,0\"\u003eFormulate proactive clinical strategies for the prevention and nutritional management of rheumatoid arthritis.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,4,0\"\u003eImplement evidence-based approaches for managing ANCA-associated vasculitis, addressing pregnancy complexities, and mitigating malignancy risks in myositis.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2 data-path-to-node=\"4\"\u003e3. Target Audience\u003c\/h2\u003e\r\nBest for rheumatologists and clinical immunologists who want updates on SLE, rheumatoid arthritis, JAK inhibitors, and spondyloarthritis.\r\n\u003ch2 data-path-to-node=\"6\"\u003e4. Topics\u003c\/h2\u003e\r\n\u003col\u003e\r\n \t\u003cli data-path-to-node=\"8,0,0\"\u003eAdjourn\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,1,0\"\u003eBiology and Rx of Lupus Flares\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,2,0\"\u003eBONUS STEP\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,3,0\"\u003eChoosing Systemic Therapies for Psoriatic Disease\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,4,0\"\u003eCurrentFuture Biomarkers in SLE\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,5,0\"\u003eEnthesitis in Spondyloarthritis\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,6,0\"\u003eEULAR vs ACR vs GRAPPA Guidelines\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,7,0\"\u003eExpanding Use of JAK Inhibitors in Dermatology\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,8,0\"\u003eFuture Therapy of Axial Spondyloarthritis\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,9,0\"\u003eGender Differences in PsA Outcomes Management\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,10,0\"\u003eGPA Managment in 2024\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,11,0\"\u003eJAK Faculty QA\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,12,0\"\u003eJAK Inhibition in Spondyloarthritis\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,13,0\"\u003eJAK Inhibitors in the Paradigm\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,14,0\"\u003eLessons from Cardio-Rheumatology Clinic\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,15,0\"\u003eMastering SLE\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,16,0\"\u003eNonradiographic Axial Spondyloarthritis\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,17,0\"\u003eNutrition in RA\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,18,0\"\u003ePrevention of RA\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,19,0\"\u003ePsoriatic Arthritis – Hot Topics\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,20,0\"\u003ePsoriatic Faculty QA\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,21,0\"\u003eRA Faculty Panel QA\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,22,0\"\u003eRethinking Pre-Clinical Disease in Lupus\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,23,0\"\u003eRheumatoid Arthritis Success in Rheumatoid Arthritis\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,24,0\"\u003eSafety Concerns with JAK Inhibitors\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,25,0\"\u003eSLE Faculty Panel QA\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,26,0\"\u003eSpondyloarthritis Faculty Panel QA\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,27,0\"\u003eSpondyloarthritis Spectrum\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,28,0\"\u003eSTEP Appreciative Rheumatology Building On The Positive\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,29,0\"\u003eSTEP Dead Words Eulogy\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,30,0\"\u003eSTEP Ethics in Rheumatology\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,31,0\"\u003eSTEP Immunosenescence in RA\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,32,0\"\u003eSTEP Lest we forget the flare\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,33,0\"\u003eSTEP Myositis Malignancy Risk Screening\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,34,0\"\u003eSTEP Myths Mistakes on ANCA-Associated Vasculitis\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,35,0\"\u003eTreat to Target in Vasculitis\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,36,0\"\u003eVasculitis Faculty Panel QA\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,37,0\"\u003eVasculitis Mavens\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,38,0\"\u003eVasculitis Pregnancy\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,39,0\"\u003eVIRTUAL SHOWCASE – Clinical Relevance of High Rheumatoid Factor in Patients With Rheumatoid Arthritis Non-CME\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,40,0\"\u003eVIRTUAL SHOWCASE – DEFY Expectations Challenge Treatment Goals in Your Adult TNFi-IR Patients with Active Psoriatic A…\u003c\/li\u003e\r\n \t\u003cli data-path-to-node=\"8,41,0\"\u003eWelcome Introductions\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954567680098,"sku":"MED-AMB06225","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/RheumNow-Live-2024.jpg?v=1779379855","url":"https:\/\/meducourse.com\/products\/rheumnow-live-2024","provider":"Meducourse","version":"1.0","type":"link"}